Jazz Pharmaceuticals Public Limited Company (JAZZ)
-NasdaqGS 63.75 
0.75(1.19%) May 24, 4:00PM EDT|After Hours
:
63.80 0.05 (0.08%) May 24, 7:17PM EDT
| Prev Close: | 63.00 |
|---|
| Open: | 62.63 |
|---|
| Bid: | 57.51 x 400 |
|---|
| Ask: | 65.32 x 600 |
|---|
| 1y Target Est: | 74.77 |
|---|
| Beta: | 0.87 |
|---|
| Next Earnings Date: | 9-Aug-13 |
|---|
| Day's Range: | 62.46 - 65.00 |
|---|
| 52wk Range: | 40.38 - 65.00 |
|---|
| Volume: | 1,209,064 |
|---|
| Avg Vol (3m): | 806,334 |
|---|
| Market Cap: | 3.75B |
|---|
| P/E (ttm): | 12.77 |
|---|
| EPS (ttm): | 4.99 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Promising Data on ONCY's ReolysinZacks(Fri, May 24)
- Elan Rejects Royalty Offer AgainZacks(Fri, May 24)
- NPS Pharma Prices OfferingZacks(Thu, May 23)
- Pfizer Halts Inotuzumab StudyZacks(Thu, May 23)
- Repros to Conduct Phase IIb TrialZacks(Thu, May 23)
- Ironwood Pharma Prices Stock OfferingZacks(Thu, May 23)
- The Zacks Analyst Blog Highlights: Zumiez, Mylan, AbbVie, Santarus and Jazz PharmaceuticalsZacks(Thu, May 23)
- Rash Of Breakouts A Bullish Sign For Foreign Stocksat Investor's Business Daily(Wed, May 22)
- Bristol-Myers, Jazz Pharmaceuticals Lead Pharma Rallyat Investor's Business Daily(Wed, May 22)
- XenoPort Resumes Horizant SupplyZacks(Wed, May 22)
- Sanofi/REGN's Dupilumab Data PublishedZacks(Wed, May 22)
- Swiss Issue for AMAG/Takeda's RiensoZacks(Wed, May 22)
- Additional Patent for Acorda's AmpyraZacks(Wed, May 22)
- Generic Launches at Mylan ContinueZacks(Wed, May 22)
- AbbVie Extends Galapagos DealZacks(Wed, May 22)
Key Statistics
| Forward P/E (1 yr): | 8.49 |
|---|
| P/S (ttm): | 5.45 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 6.15 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.52 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | 0.57 |
|---|
Business Summary
Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products for various medical needs in the United States, Europe, and other coun...
View More